FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/06/026163 [Registered on: 26/06/2020] Trial Registered Prospectively
Last Modified On: 24/06/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to evaluate the efficacy and safety of Shuddhi Vati in comparision with Lactulose in children suffering from chronic constipation 
Scientific Title of Study   A prospective, comparative, randomized trial to evaluate the clinical efficacy and safety of Shudhhi Vati (ayurvedic drug) in comparison with Lactulose (allopathic drug) in children suffering from chronic constipation  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Virendra Kumar Gupta 
Designation  Associate professor 
Affiliation  National Institute Of Medical Sciences & Research Jaipur 
Address  Department of pediatrics OPD No 3 National Institute Of Medical Sciences & Research Jaipur Jaipur

Jaipur
RAJASTHAN
303121
India 
Phone  7976406843  
Fax    
Email  vk.hindustani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Virendra Kumar Gupta 
Designation  Associate professor 
Affiliation  National Institute Of Medical Sciences & Research Jaipur 
Address  Department of pediatrics OPD No 3 National Institute Of Medical Sciences & Research Jaipur Jaipur

Jaipur
RAJASTHAN
303121
India 
Phone  7976406843  
Fax    
Email  vk.hindustani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meenaxi Sharma 
Designation  Principal 
Affiliation  National Institute of Medical Sciences & Research 
Address  Department of Anesthesia National Institute Of Medical Sciences & Research Jaipur

Jaipur
RAJASTHAN
303121
India 
Phone    
Fax    
Email  drmeenaxi@rediffmail.com  
 
Source of Monetary or Material Support  
National Institute of Medical science and Research NIMS University Rajasthan Jaipur 
 
Primary Sponsor  
Name  National Institute Of Medical Sciences Research Jaipur 
Address  NIMS university Jaipur 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Patanjali yogpeeth  Patanjli yogpeeth haridwar 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr virendra kumar gupta  National institute of medical science  Department of pediatrics OPD No 3 National Institute Of Medical Sciences & Research Jaipur
Jaipur
RAJASTHAN 
7976406843

vk.hindustani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R194||Change in bowel habit,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Lactulose  Osmotic laxative Liquid medicine: 3.1–3.7 g in 5 mL of medicine Children: 0.7 to 2 g/kg/day (1 to 3 mL/kg/day) orally in divided doses daily; generally recommended not to exceed the adult maximum of 40 g/day (60 mL/day) for 3 month  
Comparator Agent  Shudhhi vati  Ayurvedic drug use in children age 5-10 year @ 200 mg tab , 1 tab /day at bed time orally and children age 10-15 year @ 400 mg tab , 1 tab /day at bed time orally for 3 month 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  14.00 Year(s)
Gender  Both 
Details  1-Healthy children of either gender between 2-14 years of age .
2-Subject in a good clinical condition as judged by the investigator based on 3-3-3-medical history and physical examination
Written informed consent obtained from the subject’s parents or legally acceptable representative
 
 
ExclusionCriteria 
Details  1-Age less than 2 years and more than 14 years.
2-Children with associated conditions like hypothyroidism, celiac disease, Malnutrition, HIV, Malignancies and Acute or Chronic illnesses will be excluded.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Average change in passing Frequency & consistency of stool
Change in routine activity school going
 
Visit 1: Day 0 – Baseline visit
Visit 2: Day 7 – First follow-up visit
Visit 3: One month – Second follow-up visit
Visit 4: Two month – Third follow-up visit
Visit 5: Three month– Fourth follow-up visit
Visit 6: Six Month – Fifth follow-up visit
 
 
Secondary Outcome  
Outcome  TimePoints 
Passing Blood / Pain/ Distension during trial
Find any abnormal investigation parameter during trial
 
12 Months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/07/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This will be A prospective, comparative, randomized trial to evaluate the clinical efficacy and safety of Shudhhi Vati (ayurvedic drug) in comparison with Lactulose (allopathic drug) in children suffering from chronic constipation.
AIM AND OBJECTIVES:1. Increase quality of life & daily activity of children. 2. Decrease episodes of constipation.
MATERIAL AND METHODS: 

STUDY DESIGN: A Prospective, Randomized, Two arm, parallel, hospital based, non –inferiority phase III/ IV clinical study

STUDY AREA: OPD & IPD patients of NIMS hospital in department of Pediatrics

SAMPLE SIZE AND SAMPLING TECHNIQUE:

A total of 100 patients to be selected by Odd-Even Randomized sampling technique.(50 Cases in each arm)

STUDY POPULATION: Children between age 2-14 years.

STUDY PERIOD: Six Month for a case.

TIME FRAME: One Year

STASTICAL ANALYSIS: All Intragroup datas will be qualitative which will be calculated with Chi- Square test and Inter group datas will be quantitative where Unpare T test will be applicable, all datas will be plotted on SPSS 2.0 softwere

INCLUSION CRITERIA:

•      Healthy children of either gender between 2-14 years of age .

•      Subject in a good clinical condition as judged by the investigator  based on medical history and physical examination 

•      Written informed consent obtained from the subject’s parents or legally acceptable representative  

EXCLUSION CRITERIA:

•      Age less than 2 years and more than 14 years.

•      Children with associated conditions like hypothyroidism, celiac disease, Malnutrition, HIV, Malignancies and Acute or Chronic illnesses will be excluded.


METHODOLOGY: After enrollment of patient with all inclusion criteria , a odd even randamization will be applicable to the patient and two groups will be made onthe basis of drug intervention as allopathic and ayurvedic drug. After complettee treatment and follow up all results will be record.                                  

 Questionnaire for all patient:

1- Frequency to passing stool ?

          a) Daily       b) 2-4 days c) 5-7 days d) >7 Days 

2-Consistency of stool ?

           a) Liquid    b) Semi solid c) Solid     d) Hard

3- Feeling pain during passing stool ?          Yes/No

4- Bleeding during passing stool  ?    Yes/No

5-Distension of abdomen ?                          Yes/No

INVESTIGATIONS

•      At First Visit:

          Blood investigations to rule out other associated disease ( If required)

                   CBC, LFT, Free T4, TSH, Ttg-IgA, HIV    serology, Serum Electrolyte

•      In Follow up Visit:

                   Serum electrolyte and others if required


 
Close